FDA should accredit private laboratories. FDA should accredit private laboratories using ISO 17025. FDA should permit third party accreditation. Third parties should be allowed to both collect and analyze samples. FDA should provide both guidelines and performance criteria.
Accreditation is too expensive.
FDA's own laboratories must meet the same recognized standards. Protocols must be developed to handle conflicting results. Current triple value is an adequate deterrent. Establish a Commission to evaluate bond criteria and appeals. Increased bond is unneeded and restricts trade.